Piramal Pharma Q2 FY27 results

Statements (10)

1. ▲ Bullish

   Piramal Pharma reported a 15% increase in stock price following its Q2 results.

   business-standard.comOct 28, 2026 05:22 UTC
2. ▲ Bullish

   Piramal Pharma expects meaningfully higher profitability

   cnbctv18.comOct 28, 2026 04:49 UTCHigh importance
3. ▲ Bullish

   Piramal Pharma shares surge 14% as Q2 profitability improves

   cnbctv18.comOct 28, 2026 04:49 UTCHigh importance
4. ▲ Bullish

   Piramal Pharma upgrades FY27 revenue growth outlook to 19%-20%

   cnbctv18.comOct 28, 2026 04:49 UTCHigh importance
5. ● Neutral

   Piramal Pharma Limited reported results for the second quarter and first half of fiscal year 2027

   prnewswire.comOct 28, 2026 02:17 UTCHigh importance
6. ● Neutral

   Piramal Pharma Limited reported results for the second quarter and half year ended September 30, 2026

   prnewswire.comOct 27, 2026 19:28 UTCHigh importance
7. ▲ Bullish

   Piramal Pharma reported a net profit of ₹5.58 crore in Q2 FY27, up from a loss of ₹99.2 crore the previous year.

   cnbctv18.comOct 27, 2026 17:34 UTCHigh importance
8. ▲ Bullish

   Piramal Pharma upgraded its FY27 revenue growth outlook to 19%–20%.

   cnbctv18.comOct 27, 2026 17:34 UTCHigh importance
9. ▲ Bullish

   Piramal Pharma's EBITDA margin expanded to 13.3% in Q2 FY27.

   cnbctv18.comOct 27, 2026 17:34 UTC
10. ▲ Bullish

    Piramal Pharma's revenue grew 28% to ₹2,617 crore in Q2 FY27.

    cnbctv18.comOct 27, 2026 17:34 UTCHigh importance